Ocular Drug Delivery Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Ocular Drug Delivery Market to 2027 - Global Analysis and Forecasts By Technology (Topical, Iontophoresis, Ocular Insert, Intraocular Implants, In Situ Gel and Punctal Plugs, and Others); Formulation Type (Liposomes and Nanoparticles, Solution, Emulsion, Suspension and Ointment); Disease Type (Glaucoma, Diabetic Retinopathy, Dry Eye Syndrome, Macular Degeneration, Cataract, Diabetic Macular Edema and Others); End User (Hospitals, Ophthalmic Clinics, Ambulatory Surgical Centers and Homecare Settings)

Report Code: TIPRE00004206 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Ocular Drug Delivery is related to ophthalmic disease treatment that affects various parts of the eye anatomy. Ocular drugs formulations are primarily available in liquid form such as solutions, suspensions, and emulsions for treating anterior eye segment diseases.

MARKET DYNAMICS
The Ocular Drug Delivery Market is anticipated to grow in the forecast period owing to driving factors such as rising prevalence of ophthalmic diseases, increase in incidence of glaucoma and macular degeneration, increase in the number of approvals from government regulations, favorable reimbursement policies, rise in funding to develop advanced drug delivery system and low bioavailability of drugs in conventional ocular therapies. Nevertheless, discomfort of some patients and occurrence of irritation, and dilution due to the hardness of the implants is expected to retrain the market growth during the forecast period.

MARKET SCOPE
The "Global Ocular Drug Delivery Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Ocular Drug Delivery Market with detailed market segmentation by Technology, Formulation Type, Disease Type, End User and geography. The global Ocular Drug Delivery Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Ocular Drug Delivery Market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global Ocular Drug Delivery Market is segmented on the basis of Technology, Formulation Type, Disease Type, and End User. Based on Technology the market is segmented into Topical, Iontophoresis, Ocular Insert, Intraocular Implants, In Situ Gel & Punctal Plugs, and Others. Based on Formulation Type the market is segmented into Liposomes & Nanoparticles, Solution, Emulsion, Suspension and Ointment. Based on Disease Type the market is segmented into Glaucoma, Diabetic Retinopathy, Dry Eye Syndrome, Macular Degeneration, Cataract, Diabetic Macular Edema and Others. Based on End User the market is segmented into Hospitals, Ophthalmic Clinics, Ambulatory Surgical Centers and Homecare Settings.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Ocular Drug Delivery Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Ocular Drug Delivery Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Ocular Drug Delivery Market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Ocular Drug Delivery Market in these regions.

MARKET PLAYERS
The reports cover key developments in the Ocular Drug Delivery Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Ocular Drug Delivery Market are anticipated to lucrative growth opportunities in the future with the rising demand for Ocular Drug Delivery Market in the global market. Below mentioned is the list of few companies engaged in the Ocular Drug Delivery Market.

The report also includes the profiles of key Ocular Drug Delivery Market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Valeant Pharmaceuticals International, Inc
  • Taiwan Liposome Company, Ltd
  • Ocular Therapeutix, Inc
  • Graybug Vision Inc
  • Eyegate Pharma
  • Clearside Biomedical, Inc
  • Alimera Sciences
  • Envisia Therapeutics
  • Allergan, Plc
  • Novartis
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Ocular Drug Delivery Market - By Technology
1.3.2 Ocular Drug Delivery Market - By Formulation Type
1.3.3 Ocular Drug Delivery Market - By Disease Type
1.3.4 Ocular Drug Delivery Market - By End User
1.3.5 Ocular Drug Delivery Market - By Region
1.3.5.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. OCULAR DRUG DELIVERY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. OCULAR DRUG DELIVERY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. OCULAR DRUG DELIVERY MARKET - GLOBAL MARKET ANALYSIS
6.1. OCULAR DRUG DELIVERY - GLOBAL MARKET OVERVIEW
6.2. OCULAR DRUG DELIVERY - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. OCULAR DRUG DELIVERY MARKET - REVENUE AND FORECASTS TO 2027 - TECHNOLOGY
7.1. OVERVIEW
7.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
7.3. TOPICAL
7.3.1. Overview
7.3.2. Topical Market Forecast and Analysis
7.4. IONTOPHORESIS
7.4.1. Overview
7.4.2. Iontophoresis Market Forecast and Analysis
7.5. OCULAR INSERT
7.5.1. Overview
7.5.2. Ocular Insert Market Forecast and Analysis
7.6. INTRAOCULAR IMPLANTS
7.6.1. Overview
7.6.2. Intraocular Implants Market Forecast and Analysis
7.7. IN SITU GEL AND PUNCTAL PLUGS
7.7.1. Overview
7.7.2. In Situ Gel and Punctal Plugs Market Forecast and Analysis
7.8. AND OTHERS
7.8.1. Overview
7.8.2. and Others Market Forecast and Analysis
8. OCULAR DRUG DELIVERY MARKET - REVENUE AND FORECASTS TO 2027 - FORMULATION TYPE
8.1. OVERVIEW
8.2. FORMULATION TYPE MARKET FORECASTS AND ANALYSIS
8.3. LIPOSOMES AND NANOPARTICLES
8.3.1. Overview
8.3.2. Liposomes and Nanoparticles Market Forecast and Analysis
8.4. SOLUTION
8.4.1. Overview
8.4.2. Solution Market Forecast and Analysis
8.5. EMULSION
8.5.1. Overview
8.5.2. Emulsion Market Forecast and Analysis
8.6. SUSPENSION AND OINTMENT
8.6.1. Overview
8.6.2. Suspension and Ointment Market Forecast and Analysis
9. OCULAR DRUG DELIVERY MARKET - REVENUE AND FORECASTS TO 2027 - DISEASE TYPE
9.1. OVERVIEW
9.2. DISEASE TYPE MARKET FORECASTS AND ANALYSIS
9.3. GLAUCOMA
9.3.1. Overview
9.3.2. Glaucoma Market Forecast and Analysis
9.4. DIABETIC RETINOPATHY
9.4.1. Overview
9.4.2. Diabetic Retinopathy Market Forecast and Analysis
9.5. DRY EYE SYNDROME
9.5.1. Overview
9.5.2. Dry Eye Syndrome Market Forecast and Analysis
9.6. MACULAR DEGENERATION
9.6.1. Overview
9.6.2. Macular Degeneration Market Forecast and Analysis
9.7. CATARACT
9.7.1. Overview
9.7.2. Cataract Market Forecast and Analysis
9.8. DIABETIC MACULAR EDEMA AND OTHERS
9.8.1. Overview
9.8.2. Diabetic Macular Edema and Others Market Forecast and Analysis
10. OCULAR DRUG DELIVERY MARKET - REVENUE AND FORECASTS TO 2027 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. HOSPITALS
10.3.1. Overview
10.3.2. Hospitals Market Forecast and Analysis
10.4. OPHTHALMIC CLINICS
10.4.1. Overview
10.4.2. Ophthalmic Clinics Market Forecast and Analysis
10.5. AMBULATORY SURGICAL CENTERS AND HOMECARE SETTINGS
10.5.1. Overview
10.5.2. Ambulatory Surgical Centers and Homecare Settings Market Forecast and Analysis
11. OCULAR DRUG DELIVERY MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Ocular Drug Delivery Market Overview
11.1.2 North America Ocular Drug Delivery Market Forecasts and Analysis
11.1.3 North America Ocular Drug Delivery Market Forecasts and Analysis - By Technology
11.1.4 North America Ocular Drug Delivery Market Forecasts and Analysis - By Formulation Type
11.1.5 North America Ocular Drug Delivery Market Forecasts and Analysis - By Disease Type
11.1.6 North America Ocular Drug Delivery Market Forecasts and Analysis - By End User
11.1.7 North America Ocular Drug Delivery Market Forecasts and Analysis - By Countries
11.1.7.1 United States Ocular Drug Delivery Market
11.1.7.1.1 United States Ocular Drug Delivery Market by Technology
11.1.7.1.2 United States Ocular Drug Delivery Market by Formulation Type
11.1.7.1.3 United States Ocular Drug Delivery Market by Disease Type
11.1.7.1.4 United States Ocular Drug Delivery Market by End User
11.1.7.2 Canada Ocular Drug Delivery Market
11.1.7.2.1 Canada Ocular Drug Delivery Market by Technology
11.1.7.2.2 Canada Ocular Drug Delivery Market by Formulation Type
11.1.7.2.3 Canada Ocular Drug Delivery Market by Disease Type
11.1.7.2.4 Canada Ocular Drug Delivery Market by End User
11.1.7.3 Mexico Ocular Drug Delivery Market
11.1.7.3.1 Mexico Ocular Drug Delivery Market by Technology
11.1.7.3.2 Mexico Ocular Drug Delivery Market by Formulation Type
11.1.7.3.3 Mexico Ocular Drug Delivery Market by Disease Type
11.1.7.3.4 Mexico Ocular Drug Delivery Market by End User
11.1.7.4 US Ocular Drug Delivery Market
11.1.7.4.1 US Ocular Drug Delivery Market by Technology
11.1.7.4.2 US Ocular Drug Delivery Market by Formulation Type
11.1.7.4.3 US Ocular Drug Delivery Market by Disease Type
11.1.7.4.4 US Ocular Drug Delivery Market by End User
11.2. EUROPE
11.2.1 Europe Ocular Drug Delivery Market Overview
11.2.2 Europe Ocular Drug Delivery Market Forecasts and Analysis
11.2.3 Europe Ocular Drug Delivery Market Forecasts and Analysis - By Technology
11.2.4 Europe Ocular Drug Delivery Market Forecasts and Analysis - By Formulation Type
11.2.5 Europe Ocular Drug Delivery Market Forecasts and Analysis - By Disease Type
11.2.6 Europe Ocular Drug Delivery Market Forecasts and Analysis - By End User
11.2.7 Europe Ocular Drug Delivery Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Ocular Drug Delivery Market
11.2.7.1.1 Germany Ocular Drug Delivery Market by Technology
11.2.7.1.2 Germany Ocular Drug Delivery Market by Formulation Type
11.2.7.1.3 Germany Ocular Drug Delivery Market by Disease Type
11.2.7.1.4 Germany Ocular Drug Delivery Market by End User
11.2.7.2 France Ocular Drug Delivery Market
11.2.7.2.1 France Ocular Drug Delivery Market by Technology
11.2.7.2.2 France Ocular Drug Delivery Market by Formulation Type
11.2.7.2.3 France Ocular Drug Delivery Market by Disease Type
11.2.7.2.4 France Ocular Drug Delivery Market by End User
11.2.7.3 Italy Ocular Drug Delivery Market
11.2.7.3.1 Italy Ocular Drug Delivery Market by Technology
11.2.7.3.2 Italy Ocular Drug Delivery Market by Formulation Type
11.2.7.3.3 Italy Ocular Drug Delivery Market by Disease Type
11.2.7.3.4 Italy Ocular Drug Delivery Market by End User
11.2.7.4 Spain Ocular Drug Delivery Market
11.2.7.4.1 Spain Ocular Drug Delivery Market by Technology
11.2.7.4.2 Spain Ocular Drug Delivery Market by Formulation Type
11.2.7.4.3 Spain Ocular Drug Delivery Market by Disease Type
11.2.7.4.4 Spain Ocular Drug Delivery Market by End User
11.2.7.5 United Kingdom Ocular Drug Delivery Market
11.2.7.5.1 United Kingdom Ocular Drug Delivery Market by Technology
11.2.7.5.2 United Kingdom Ocular Drug Delivery Market by Formulation Type
11.2.7.5.3 United Kingdom Ocular Drug Delivery Market by Disease Type
11.2.7.5.4 United Kingdom Ocular Drug Delivery Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Ocular Drug Delivery Market Overview
11.3.2 Asia-Pacific Ocular Drug Delivery Market Forecasts and Analysis
11.3.3 Asia-Pacific Ocular Drug Delivery Market Forecasts and Analysis - By Technology
11.3.4 Asia-Pacific Ocular Drug Delivery Market Forecasts and Analysis - By Formulation Type
11.3.5 Asia-Pacific Ocular Drug Delivery Market Forecasts and Analysis - By Disease Type
11.3.6 Asia-Pacific Ocular Drug Delivery Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific Ocular Drug Delivery Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Ocular Drug Delivery Market
11.3.7.1.1 Australia Ocular Drug Delivery Market by Technology
11.3.7.1.2 Australia Ocular Drug Delivery Market by Formulation Type
11.3.7.1.3 Australia Ocular Drug Delivery Market by Disease Type
11.3.7.1.4 Australia Ocular Drug Delivery Market by End User
11.3.7.2 China Ocular Drug Delivery Market
11.3.7.2.1 China Ocular Drug Delivery Market by Technology
11.3.7.2.2 China Ocular Drug Delivery Market by Formulation Type
11.3.7.2.3 China Ocular Drug Delivery Market by Disease Type
11.3.7.2.4 China Ocular Drug Delivery Market by End User
11.3.7.3 India Ocular Drug Delivery Market
11.3.7.3.1 India Ocular Drug Delivery Market by Technology
11.3.7.3.2 India Ocular Drug Delivery Market by Formulation Type
11.3.7.3.3 India Ocular Drug Delivery Market by Disease Type
11.3.7.3.4 India Ocular Drug Delivery Market by End User
11.3.7.4 Japan Ocular Drug Delivery Market
11.3.7.4.1 Japan Ocular Drug Delivery Market by Technology
11.3.7.4.2 Japan Ocular Drug Delivery Market by Formulation Type
11.3.7.4.3 Japan Ocular Drug Delivery Market by Disease Type
11.3.7.4.4 Japan Ocular Drug Delivery Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Ocular Drug Delivery Market Overview
11.4.2 Middle East and Africa Ocular Drug Delivery Market Forecasts and Analysis
11.4.3 Middle East and Africa Ocular Drug Delivery Market Forecasts and Analysis - By Technology
11.4.4 Middle East and Africa Ocular Drug Delivery Market Forecasts and Analysis - By Formulation Type
11.4.5 Middle East and Africa Ocular Drug Delivery Market Forecasts and Analysis - By Disease Type
11.4.6 Middle East and Africa Ocular Drug Delivery Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa Ocular Drug Delivery Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Ocular Drug Delivery Market
11.4.7.1.1 South Africa Ocular Drug Delivery Market by Technology
11.4.7.1.2 South Africa Ocular Drug Delivery Market by Formulation Type
11.4.7.1.3 South Africa Ocular Drug Delivery Market by Disease Type
11.4.7.1.4 South Africa Ocular Drug Delivery Market by End User
11.4.7.2 Saudi Arabia Ocular Drug Delivery Market
11.4.7.2.1 Saudi Arabia Ocular Drug Delivery Market by Technology
11.4.7.2.2 Saudi Arabia Ocular Drug Delivery Market by Formulation Type
11.4.7.2.3 Saudi Arabia Ocular Drug Delivery Market by Disease Type
11.4.7.2.4 Saudi Arabia Ocular Drug Delivery Market by End User
11.4.7.3 U.A.E Ocular Drug Delivery Market
11.4.7.3.1 U.A.E Ocular Drug Delivery Market by Technology
11.4.7.3.2 U.A.E Ocular Drug Delivery Market by Formulation Type
11.4.7.3.3 U.A.E Ocular Drug Delivery Market by Disease Type
11.4.7.3.4 U.A.E Ocular Drug Delivery Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Ocular Drug Delivery Market Overview
11.5.2 South and Central America Ocular Drug Delivery Market Forecasts and Analysis
11.5.3 South and Central America Ocular Drug Delivery Market Forecasts and Analysis - By Technology
11.5.4 South and Central America Ocular Drug Delivery Market Forecasts and Analysis - By Formulation Type
11.5.5 South and Central America Ocular Drug Delivery Market Forecasts and Analysis - By Disease Type
11.5.6 South and Central America Ocular Drug Delivery Market Forecasts and Analysis - By End User
11.5.7 South and Central America Ocular Drug Delivery Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Ocular Drug Delivery Market
11.5.7.1.1 Brazil Ocular Drug Delivery Market by Technology
11.5.7.1.2 Brazil Ocular Drug Delivery Market by Formulation Type
11.5.7.1.3 Brazil Ocular Drug Delivery Market by Disease Type
11.5.7.1.4 Brazil Ocular Drug Delivery Market by End User
11.5.7.2 Argentina Ocular Drug Delivery Market
11.5.7.2.1 Argentina Ocular Drug Delivery Market by Technology
11.5.7.2.2 Argentina Ocular Drug Delivery Market by Formulation Type
11.5.7.2.3 Argentina Ocular Drug Delivery Market by Disease Type
11.5.7.2.4 Argentina Ocular Drug Delivery Market by End User
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. OCULAR DRUG DELIVERY MARKET, KEY COMPANY PROFILES
13.1. VALEANT PHARMACEUTICALS INTERNATIONAL, INC
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. TAIWAN LIPOSOME COMPANY, LTD
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. OCULAR THERAPEUTIX, INC
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. GRAYBUG VISION INC
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. EYEGATE PHARM
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. CLEARSIDE BIOMEDICAL, INC
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. ALIMERA SCIENCES
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. ENVISIA THERAPEUTICS
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. ALLERGAN, PLC
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. NOVARTIS
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

- Valeant Pharmaceuticals International, Inc
- Taiwan Liposome Company, Ltd
- Ocular Therapeutix, Inc
- Graybug Vision Inc
- Eyegate Pharma
- Clearside Biomedical, Inc
- Alimera Sciences
- Envisia Therapeutics
- Allergan, Plc
- Novartis